Aspen Oss
Aspen Oss B.V. develops and produces more than 50 complex Active Pharmaceutical Ingredients — including heparin, steroids, peptides, and hormones — for global pharmaceutical manufacturers. A wholly-owned subsidiary of Aspen Pharmacare Holdings Limited, it operates three Dutch production facilities plus international sites in the USA and South Africa.
- Company typePrivate
- Founded1923
- HeadquartersDurban, South Africa
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Aspen Oss does
Aspen Oss B.V. is a Netherlands-based developer and manufacturer of complex Active Pharmaceutical Ingredients (APIs) and a wholly-owned subsidiary of Aspen Pharmacare Holdings Limited (JSE: APN), the South African-headquartered pharmaceutical group. The company produces more than 50 different APIs — including heparin sodium (blood thinners), hormonal APIs/steroids, peptides, alkaloids, heterocyclic compounds, and Chorionic Gonadotrophin (hCG) for fertility treatments — that are processed into finished medicines such as contraceptives, anesthesia products, muscle relaxants, and fertility therapies. The business traces its heritage to NV Organon, founded in 1923 in Oss by Salomon van Zwanenberg and Ernst Laqueur, who pioneered insulin isolation in the 1920s and the Lyndiol contraceptive pill in the 1960s.
The company operates three primary Dutch production sites — Moleneind (peptides and small-scale hormonal/chemical APIs), De Geer (highly potent APIs via computer-controlled multifunctional reactors up to 10,000 liters), and Boxtel (hCG processing via the Moeders voor Moeders urine-collection program) — supported by a crude heparin collection site in Sioux City, Iowa (USA) and Fine Chemicals Corporation (FCC) in Cape Town, South Africa. Technical capabilities include a dedicated API Powder Processing Department (APPD) for sieving, milling, micronising, and homogenisation; modern DTS laboratories where more than half of staff hold BSc, MSc, or PhD qualifications; and a Manufacturing Execution System (MES) for digital batch data registration. The Quality Assurance & Control function enforces GMP compliance across all sites. Aspen Oss has documented a greater than 50% reduction in solvent emissions, water consumption, and energy use under its sustainability program.
The business runs a B2B enterprise sales model, selling APIs directly to global pharmaceutical manufacturers through an in-house Commercial Department handling marketing, sales, new product strategy, and customer service. APIs are sold under long-term supply relationships anchored by multi-year regulatory qualification cycles. Customer types are enterprise pharmaceutical manufacturers producing finished dosage forms across multiple therapeutic categories; no end-customer logos are publicly disclosed. The company positions itself as a solution provider rather than a commodity supplier and is pursuing an explicit 'Aspire' growth strategy targeting 3x scale-up to become a 'one billion company' through new product launches, new geographic markets, and customer-base expansion, leveraging its parent group's commercial presence in 115+ countries.
Aspen Oss firmographics
Firmographics- Name
- Aspen Oss
- Legal name
- Aspen Oss B.V.
- Website
- https://werkenbijaspen.nl
- Company type
- Private
- Founded year
- 1923
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Aspen Oss B.V. develops and produces more than 50 complex Active Pharmaceutical Ingredients — including heparin, steroids, peptides, and hormones — for global pharmaceutical manufacturers. A wholly-owned subsidiary of Aspen Pharmacare Holdings Limited, it operates three Dutch production facilities plus international sites in the USA and South Africa.
- Ownership category
- akta.pro rank
Aspen Oss industry classification
Industry- Product category
- Active Pharmaceutical Ingredient (API) Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic APIs & Intermediates (Active Ingredients) (HLAIABAG)
- akta.pro secondary industry
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)
Keywords
Where Aspen Oss is headquartered
LocationHeadquarters
- HQ city
- Durban
- HQ country
- South Africa
- HQ region
- Africa
Offices6 records
Markets served
Aspen Oss business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Infrastructure, Supply Chain, Technology or R&D, Operations
Revenue model
- Active Pharmaceutical Ingredients (API) Manufacturing and Sales: Development, production and global sale of complex, high-quality chemical and biochemical Active Pharmaceutical Ingredients (APIs) including heparin, hormones, peptides and steroids. These APIs are sold to pharmaceutical manufacturers worldwide and are processed into medicines such as blood thinners, muscle relaxants, contraception and anesthesia products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Operator APPD position with shift allowances |
| Subscription | Monthly | Manager Commercial Excellence & Operations (Scale P3) |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Aspen Oss product offering
Product offeringCore offering
Aspen Oss develops, produces, and globally sells complex, high-quality Active Pharmaceutical Ingredients (APIs), including heparin sodium, hormonal APIs (steroids), peptides, alkaloids, and heterocyclic compounds. These APIs are supplied to pharmaceutical manufacturers worldwide as the active components in finished medicines such as blood thinners, contraceptives, muscle relaxants, anesthesia, and fertility treatments. The company operates an integrated international API manufacturing network across the Netherlands, USA, and South Africa.
Product overview
Aspen Oss is a pharmaceutical manufacturing company that develops and produces complex, high-quality Active Pharmaceutical Ingredients (APIs). The company operates with more than 50 different APIs including heparin sodium, hormones (steroids), peptides, and various heterocyclic compounds. These APIs are processed into medicines including blood thinners, muscle relaxants, contraception, and anesthesia products. The company operates across three Dutch facilities (Moleneind, De Geer in Oss, and Boxtel), with international production in Sioux City, Iowa (USA) and Cape Town, South Africa (Fine Chemicals Corporation). The operational divisions include Chemical Operations (divided into steroids, alkaloids, peptides, and other compounds), Quality Assurance/Control, Development & Technical Operations (DTS), Technical Affairs, Supply Chain Management, and Commercial Department. Aspen Oss is part of the Aspen Group with headquarters in Durban, South Africa.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 100 years of continuous API production excellence since 1923
- +3 more outcomes
Companies that use Aspen Oss
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Aspen Oss technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Aspen Oss partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Aspen GroupcoreAspen API is a wholly owned subsidiary of Aspen Pharmacare Holdings Limited, an internationally leading pharmaceutical manufacturer headquartered in Durban, South Africa. Aspen Group improves patient health in more than 115 countries with high-quality and affordable medicines, with operations in over 50 countries, 69 offices, and 23 production facilities across 6 continents.
- Fine Chemicals Corporation (FCC)coreFine Chemicals Corporation (FCC) in Cape Town, South Africa is a fully owned subsidiary of Aspen API. Specializes in large-scale production of generic APIs and highly potent APIs in ten production buildings, forming a key part of the international API network.
- Moeders voor MoederscoreMoeders voor Moeders collects approximately 1 million liters of urine from pregnant women annually, which is processed at Aspen API's Boxtel facility into Chorionic Gonadotrophin (hCG), an API used in fertility treatments.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Aspen Oss competitors and assessment
Company assessmentDirect peers
- EUROAPI: Spun off from Sanofi in 2022, EUROAPI is a leading European API manufacturer with deep exposure to heparin, hormones and complex small molecules. It is the closest European-headquartered peer to Aspen Oss in terms of product mix (steroids, peptides, heparin), regulatory complexity, and customer base of global generics producers.
- Hovione: Portuguese CDMO/API specialist with deep expertise in complex small molecules, peptides, and HPAPIs. Hovione's focus on difficult-to-make chemistries and contract manufacturing models closely parallels Aspen Oss's complex small-molecule and HPAPI positioning.
- Siegfried Holding: Swiss-headquartered API manufacturer with a portfolio spanning opiates, controlled substances, sterile injectables and complex small molecules following its 2020 acquisition of Novartis's API business. Highly comparable on regulatory intensity, complex chemistry, and customer-overlap with global pharma manufacturers.
- Piramal Pharma Solutions: Indian-headquartered CDMO and API manufacturer with significant complex-API and HPAPI capabilities serving global generics and innovator customers. Comparable on scale, customer base, and HPAPI/steroid categories directly relevant to Aspen Oss.
- WuXi STA (WuXi AppTec): Chinese CDMO/API manufacturer with large-scale small-molecule and complex API capacity serving global pharma customers. A direct competitor in contract API supply and a key source of pricing pressure on European producers like Aspen Oss.
- Centrient Pharmaceuticals: Netherlands-based (formerly DSM Sinochem Pharmaceuticals) manufacturer of generic APIs including beta-lactams and statins, with strong small-molecule API heritage. Centrient is a comparable Dutch-headquartered complex API producer serving similar global pharma customers.
- Dishman Carbogen Amcis: India-based API and contract manufacturer specializing in complex chemistry, HPAPIs, vitamin D analogues, and peptides. Highly comparable in product complexity and customer overlap with Aspen Oss.
Broad incumbents
- Lonza: Swiss-headquartered global CDMO with a substantial API and small-molecule manufacturing footprint. While Lonza spans biologics and cell & gene therapies, its small-molecule API business (including the former Bend Research) is a broad incumbent comparable to Aspen Oss's complex API offering.
- Teva API: API division of Teva Pharmaceutical, one of the world's largest generic manufacturers with vertically integrated complex API production including steroids. Comparable as a broad incumbent with overlapping HPAPI/steroid capabilities and global pharma customer base.
- Polpharma Biologics / Sanofi API: Central European pharma manufacturer with API operations supplying steroids and hormones at scale. Comparable as a regional incumbent producing overlapping complex small-molecule and hormone APIs for global generics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Aspen Oss social profiles
Digital presenceAspen Oss financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aspen Oss leadership team
Management profileNumber of profiles
Aspen Oss subsidiaries and ownership
Company hierarchySubsidiaries2 records
Aspen Oss funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aspen Oss M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aspen Oss
What does Aspen Oss do?
Aspen Oss develops, produces, and globally sells complex, high-quality Active Pharmaceutical Ingredients (APIs), including heparin sodium, hormonal APIs (steroids), peptides, alkaloids, and heterocyclic compounds. These APIs are supplied to pharmaceutical manufacturers worldwide as the active components in finished medicines such as blood thinners, contraceptives, muscle relaxants, anesthesia, and fertility treatments. The company operates an integrated international API manufacturing network across the Netherlands, USA, and South Africa.
Is Aspen Oss a public or private company?
Aspen Oss is a private company. It is classified as corporate owned and is currently operating.
When was Aspen Oss founded?
Aspen Oss was founded in 1923. It employs 11 to 50 people.
Where is Aspen Oss based?
Aspen Oss is headquartered in Durban, South Africa, in the Africa region.
How does Aspen Oss make money?
One revenue line is on record: active Pharmaceutical Ingredients (API) Manufacturing and Sales.
Who are Aspen Oss's main competitors?
Direct peers on record are EUROAPI, Hovione, Siegfried Holding, Piramal Pharma Solutions, WuXi STA (WuXi AppTec), Centrient Pharmaceuticals and Dishman Carbogen Amcis. Broad incumbents are Lonza, Teva API and Polpharma Biologics / Sanofi API.
Does Aspen Oss have an API?
No public API is recorded for Aspen Oss.
What industry is Aspen Oss in?
Aspen Oss's product category is Active Pharmaceutical Ingredient (API) Manufacturing. Its primary akta.pro industry code is HLAIABAG, Generic APIs & Intermediates (Active Ingredients), with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 325412 and its SIC code is 2834.